Ginkgo bioworks to hold special meeting of shareholders

Special meeting to take place virtually on august 14, 2024 at 4:00 pm et boston, aug. 2, 2024 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna, "ginkgo"), which is building the leading platform for cell programming and biosecurity, will be holding a special meeting of shareholders virtually on august 14, 2024 at 4:00 pm et to vote to permit, at the discretion of the board of directors, a reverse stock split of the issued and outstanding shares of class a common stock and class b common stock in a range of not less than one-for-twenty (1:20) and not more than one-for-forty (1:40), with the final ratio to be determined by the board of directors. shareholders will also vote to approve ginkgo's amended and restated certificate of incorporation, which has been updated to permit officer exculpation and remove provisions related to our merger with soaring eagle acquisition corp. and our domestication process, which are no longer relevant to our business.
DNA Ratings Summary
DNA Quant Ranking